Flerie
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm… Read more
Flerie (FLERIE) - Total Assets
Latest total assets as of December 2025: Skr3.40 Billion SEK
Based on the latest financial reports, Flerie (FLERIE) holds total assets worth Skr3.40 Billion SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Flerie - Total Assets Trend (2016–2025)
This chart illustrates how Flerie’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Flerie - Asset Composition Analysis
Current Asset Composition (December 2025)
Flerie's total assets of Skr3.40 Billion consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 15.9% |
| Accounts Receivable | Skr228.20 Million | 6.7% |
| Inventory | Skr0.00 | 0.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Flerie's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Flerie's current assets represent 0.0% of total assets in 2025, a decrease from 100.0% in 2016.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, down from 99.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 6.7% of total assets.
Flerie Competitors by Total Assets
Key competitors of Flerie based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Flerie - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Flerie generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Flerie is currently not profitable relative to its asset base.
Flerie - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 99.89 | 31.25 | 41.93 |
| Quick Ratio | 99.89 | 31.25 | 41.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr979.00 Million | Skr 955.80 Million | Skr 432.47 Million |
Flerie - Advanced Valuation Insights
This section examines the relationship between Flerie's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.80 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -19.6% |
| Total Assets | Skr3.40 Billion |
| Market Capitalization | $46.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values Flerie's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Flerie's assets decreased by 19.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Flerie (2016–2025)
The table below shows the annual total assets of Flerie from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr3.40 Billion | -19.56% |
| 2024-12-31 | Skr4.22 Billion | +1310.64% |
| 2023-12-31 | Skr299.39 Million | -14.79% |
| 2022-12-31 | Skr351.34 Million | -21.08% |
| 2021-12-31 | Skr445.20 Million | +627.63% |
| 2020-12-31 | Skr61.18 Million | -52.60% |
| 2019-12-31 | Skr129.09 Million | +49.37% |
| 2018-12-31 | Skr86.42 Million | -31.88% |
| 2017-12-31 | Skr126.87 Million | -34.77% |
| 2016-12-31 | Skr194.49 Million | -- |